Feb. 13 at 5:52 PM
$SPRY Best comparison to this company is/was
$AGRX. AGRX had a one-of-a-kind low dose estrogen patch that was especially useful for ladies who wanted the convenience of a patch if they don't want to be constantly forgetting to take the pill. However, sales were routinely low despite benefits of the patch. The company only had this single product. It was ultimately sold to another company for pennies on the dollar.
Fast foward to SPRY's Neffy. Has clear advantages to the EpiPen. However, sales are bad and adoption is low. They have no other products to sell. I believe SPRY will ultimately go the way AGRX went.
